Opko Health (OPK) Net Equity Issued and Repurchased (2010 - 2022)
Opko Health's (OPK) quarterly Net Equity Issued and Repurchased came in at -$135000.0 in Q2 2022, up 56.17% on a YoY basis from -$86444.9 in Q2 2021, and down 199.26% quarter-over-quarter from $136000.0 in Q1 2022.
Powered by 
Analysis
Opko Health (OPK) Net Equity Issued and Repurchased (2010 - 2022) Analysis & Trends
Opko Health (OPK) has reported Net Equity Issued and Repurchased for 13 consecutive years, with -$135000.0 the latest figure, recorded in Q2 2022.
- For the quarter ending Q2 2022, Net Equity Issued and Repurchased rose 56.17% year-over-year to -$135000.0; the trailing twelve-month figure through Jun 2022 stood at $1000.0 (changed N/A YoY), and the FY2023 full-year result was -$272000.0, up 64.86% from the prior year.
- Net Equity Issued and Repurchased fell to -$135000.0 in Q2 2022 per OPK's latest filing, from $136000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $91.3 million in Q4 2018 and bottomed at -$879000.0 in Q4 2021.
- Historically, Net Equity Issued and Repurchased has averaged $13.0 million across 5 years, with a median of $308000.0 in 2021.
- The sharpest annual moves came in 2018 and 2020: Net Equity Issued and Repurchased soared 4866.54% in 2018, then sank 100.88% in 2020.
- Over 5 years, Net Equity Issued and Repurchased stood at $91.3 million in 2018, then retreated by 16.71% to $76.1 million in 2019, then slumped by 100.88% to -$669000.0 in 2020, then slumped by 31.39% to -$879000.0 in 2021, then jumped by 84.64% to -$135000.0 in 2022.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered -$135000.0, $136000.0, and -$879000.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 141.90 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Opko Health | 1.25 Bn | 945.61 Mn | 80.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -135,000.00 |
| Mar 31, 2022 | 136,000.00 |
| Dec 31, 2021 | -879,000.00 |
| Sep 30, 2021 | 879,000.00 |
| Jun 30, 2021 | -308,000.00 |
| Mar 31, 2021 | 308,000.00 |
| Dec 31, 2020 | -669,000.00 |
| Sep 30, 2020 | 669,000.00 |
| Dec 31, 2019 | 76.07 Mn |
| Mar 31, 2019 | -3,000.00 |
| Dec 31, 2018 | 91.33 Mn |
| Sep 30, 2018 | 855,000.00 |
| Jun 30, 2018 | 318,000.00 |
| Dec 31, 2017 | -1.92 Mn |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 1.87 Mn |
| Dec 31, 2016 | 2.46 Mn |
| Sep 30, 2016 | 4.20 Mn |
| Jun 30, 2016 | -242,000.00 |
| Mar 31, 2016 | 2.15 Mn |
API Access
Opko Health Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OPK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "OPK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OPK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();